Platelet-Rich and Concentrated Platelet-Poor Plasma to Reduce Air Leak Post-Lobectomy: A Randomized Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

May 31, 2010

Study Completion Date

November 30, 2010

Conditions
Lung Cancer
Interventions
PROCEDURE

Standard post-lobectomy wound care plus use of PRP and PPPc prepared by GPS and Plasmax respectively

GPS is used to create the platelet rich plasma (PRP). Plasmax is used to create the concentrated platelet-poor plasma (PPPc). Both PRP and PPPc will be used for wound care in the thoracic cavity post-lobectomy.

PROCEDURE

Standard post-lobectomy wound care

Standard post-lobectomy wound care

Trial Locations (1)

N6A 5W9

University of Western Ontario: Division of Thoracic Surgery, London

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

University of Western Ontario, Canada

OTHER

lead

Zimmer Biomet

INDUSTRY

NCT00665912 - Platelet-Rich and Concentrated Platelet-Poor Plasma to Reduce Air Leak Post-Lobectomy: A Randomized Controlled Trial | Biotech Hunter | Biotech Hunter